Skip to main content

Table 1 Patient demographics and treatments pursued

From: A personalized, web-based breast cancer decision making application: a pre-post survey

  Used tool
(N = 255)a
Did not use tool
(N = 35)a
Total
(N = 290)a
Age in years (mean [SD]) 56.8 (11.8) 60.6 (12.0) 57.2 (11.8)
Race
 White 236 (92.5%) 31 (88.6%) 267 (92.1%)
 African American 1 (0.4%) 1 (2.9%) 2 (0.7%)
 American Indian/Alaskan Native 4 (1.6%) 0 (0.0%) 4 (1.4%)
 Asian 7 (2.7%) 2 (5.7%) 9 (3.1%)
 Other 2 (0.8%) 0 (0.0%) 2 (0.7%)
 Unknown or choose not to disclose 5 (2.0%) 1 (2.9%) 6 (2.1%)
Education
 Some high school (HS), did not graduate 1 (0.4%) 0 (0.0%) 1 (0.3%)
 HS graduate or GED 35 (13.8%) 12 (35.3%) 47 (16.3%)
 Some college or 2-year degree 81 (31.9%) 8 (23.5%) 89 (30.9%)
 4-year college graduate 69 (27.2%) 8 (23.5%) 77 (26.7%)
 Post graduate studies 68 (26.8%) 6 (17.6%) 74 (25.7%)
Preferred decision making approach
 I make decision 5 (2.2%) 3 (8.6%) 8 (3.0%)
 I make decision & consider doctor’s opinion 68 (29.4%) 11 (31.4%) 79 (29.7%)
 Shared decision making 144 (62.3%) 18 (51.4%) 162 (60.9%)
 Doctor makes decision & considers my opinion 11 (4.8%) 3 (8.6%) 14 (5.3%)
 Doctor makes decision 3 (1.3%) 0 (0.0%) 3 (1.1%)
Breast cancer stage
 Stage 0 35 (16.2%) 3 (12.0%) 38 (15.8%)
 Stage I 97 (44.9%) 13 (52.0%) 110 (45.6%)
 Stage II 66 (30.6%) 5 (20.0%) 71 (29.5%)
 Stage III 18 (8.3%) 4 (16.0%) 22 (9.1%)
Breast cancer laterality
 Bilateral 11 (4.9%) 4 (14.8%) 15 (5.9%)
 Unilateral 215 (95.1%) 23 (85.2%) 238 (94.1%)
Breast cancer type
 Bilateral (discordant) 6 (2.7%) 1 (3.7%) 7 (2.8%)
 Ductal carcinoma in situ 39 (17.3%) 3 (11.1%) 42 (16.7%)
 Invasive 180 (80.0%) 23 (85.2%) 203 (80.6%)
Hormonal therapyb
 Adjuvant 139/226 (61.5%) 17/27 (63.0%) 156/253 (61.7%)
 Neoadjuvant 13/226 (5.8%) 0/27 (0.0%) 13/253 (5.1%)
Chemotherapyb
 Adjuvant 36/226 (15.9%) 6/27 (22.2%) 42/253 (16.6%)
 Neoadjuvant 13/226 (5.8%) 0/27 (0.0%) 13/253 (5.1%)
Radiation therapyb 133/226 (58.8%) 18/27 (66.7%) 151/253 (59.7%)
Surgeryb
 Lumpectomy 123/226 (54.4%) 14/27 (51.9%) 137/253 (54.2%)
 Unilateral mastectomy 44/226 (19.5%) 4/27 (14.8%) 48/253 (19.0%)
 Bilateral mastectomy 59/226 (26.1%) 8/27 (29.6%) 67/253 (26.5%)
 Reconstructive surgery 75/226 (33.2%) 6/27 (22.2%) 81/253 (32.0%)
  1. aFrequencies not adding to column total indicate missing data (not included in denominator for percentages)
  2. bCategories not mutually exclusive (denominators provided)